TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.
暂无分享，去创建一个
O. Kallioniemi | R. Skotheim | M. Wolf | J. Schalken | K. Iljin | G. Verhaegh | H. Edgren | S. Kilpinen | M. Nees | F. Smit | M. Peltola | Santosh Gupta | Mari T. Peltola